跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DHACTULOSE SYRUP - HSA Drug Approval Details
Approvals
/
HSA
/
DHACTULOSE SYRUP
Approved
THERAPEUTIC
DHACTULOSE SYRUP
PT ACTAVIS INDONESIA (INDONESIA REP OF)
🇸🇬 Health Sciences Authority
Approval Date
Apr 25, 2001
Approval ID
be4d90e6665cda0a
Company
PT ACTAVIS INDONESIA (INDONESIA REP OF)
Type
Therapeutic
Approval Details
Approval Id
be4d90e6665cda0a
Drug Name
DHACTULOSE SYRUP
Product Name
DHACTULOSE SYRUP
Approval Number
SIN11494P
Approval Date
2001-04-25
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
A06AD11
Atc Item Name
lactulose
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Active Ingredients
LACTULOSE
3.35 g/5 ml
LACTULOSE
3.35 G/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 25, 2001
Approval ID
be4d90e6665cda0a
Type
Therapeutic
Back to HSA Approvals